Registration
Welcome & Opening Remarks
Harjit Gill
  • Harjit Gill (CEO of APACMed)

    Harjit Gill

    CEO of APACMed
Entrepreneurship is about Creating Value
Sundeep Shrivastava

The healthcare industry is transitioning from a fee-for-service payment model to a value-based purchasing model. To thrive in this transformative age, medtechs must build / adapt their business models to meet the increased expectations of consumers and other healthcare stakeholders. Is value the holy grail for every company? Definitely it is something executives, investors and researchers are interested in since decades

  • Sundeep Shrivastava (Executive Director, Strategic Development, Medical Device & Diagnostics of Premier Research)

    Sundeep Shrivastava

    Executive Director, Strategic Development, Medical Device & Diagnostics of Premier Research
Value & Social Innovation in Healthcare
Calvin Chu

Social innovation opens up for new ways of creating value, solving problems – and doing business. Social innovation will be an increasingly crucial competitive advantage as MedTech startups look to innovation to tackle the big social challenges that affect us such as our ageing population or public health issues.

  • Calvin Chu (Partner at Eden Strategy Institute)

    Calvin Chu

    Partner at Eden Strategy Institute
Refreshment and Networking
Regulatory Sandbox for MedTech Innovation
Binh Thai

The MedTech industry has grown significantly in Asia Pacific. Innovations brought about by this growth pose a series of challenges for regulators. As MedTech startups continue to create value, can MedTech innovation be compliant? XXX will discuss the emergence and impact of regulatory sandboxes in MedTech.

  • Binh Thai (General Manager at Asia Actual)

    Binh Thai

    General Manager at Asia Actual
Intellectual Property, Innovation & MedTech
Dr Lye Whye Kei

Intellectual Property (IP) has always been paramount to any innovative MedTech company’s success. Having a concrete understanding of your product value can help you secure a strong valuation or the financing you need. Securing IP protection immediately communicates the value-add to investors.

  • Dr Lye Whye Kei (Director, Future Health Care of NTUitive)

    Dr Lye Whye Kei

    Director, Future Health Care of NTUitive
Make Reimbursement a Part of your Business Plan
Virginia Priest

Reimbursement mechanisms are vital to the MedTech industry but many start-ups are still figuring out how to navigate this complex system. Understanding the reimbursement landscape across the diverse APAC region will help to inform innovative business strategies and may play an important role in fostering attractiveness to investors.

  • Virginia Priest (Head of Health Economics and Market Access, Asia Pacific at Boston Scientific)

    Virginia Priest

    Head of Health Economics and Market Access, Asia Pacific at Boston Scientific
Networking Lunch
VC-Funded Start-up: Is your Start-up Investor Ready?
Seemant Jauhari

MedTech startups have to convince investors that their innovations are worth their investment. It is a delicate dance to find the right potential investor with a tolerance for the risk and the long-term horizon to profitability while also requiring deep pockets for product development. How can we find aligned startup investors at each stages of development – from seed stage to startup stage and expansion stage?

  • Seemant Jauhari (Partner at HealthXCapital)

    Seemant Jauhari

    Partner at HealthXCapital
Corporation-Supported Start-up: Accelerating innovation
Nilesh Wadhwa

The world's leading enterprises are now playing an important role in driving external innovation to help entrepreneurs turn ideas into products. Do startup-corporate partnerships offer the greatest opportunity for corporate innovation? Let’s hear it from Johnson & Johnson, who is investing in, building, and partnering with technology companies to improve lives.

  • Nilesh Wadhwa (Director New Ventures and Transactions, Asia Pacific Innovation Centre of Johnson & Johnson Innovation LLC)

    Nilesh Wadhwa

    Director New Ventures and Transactions, Asia Pacific Innovation Centre of Johnson & Johnson Innovation LLC
Clinician-Invested Start-up: MedTech Needs More Active Doctors
Jack Tan

Are physicians better than technology investors, who might not have a sense of many complexities and nuances in the healthcare sector? Clinical investors don’t buy with the hear, they buy with their head. We hear from Dr. Tan on how clinical leaders and contribute to shape health innovation.

  • Jack Tan (Founding Chairman & Director of Northeast Medical Group)

    Jack Tan

    Founding Chairman & Director of Northeast Medical Group
Refreshment and Networking
Digitalization Accelerates Start-up to Commercialisation
Virginia Chan

A new era of digital innovation in medical devices are driving growth in global medical devices industry to US$500 billion in 2018, with APAC leading the growth. Virginia will share with us how medical devices and digital health start-ups in APAC can accelerate time-to-market and global market expansion with digital innovation, smart regulatory compliance and smart manufacturing.

  • Virginia Chan (Head of Digital Transformation, Medical Devices Industry, APAC at Siemens Digital Industries Software)

    Virginia Chan

    Head of Digital Transformation, Medical Devices Industry, APAC at Siemens Digital Industries Software
Collaborate to Innovate
Anselm TanKenath Priyanka PrasadHui Hong SeowChris Hardesty

Innovation is key to sustainable success, and startups, corporates and care providers are coming together to accelerate innovation. This is a hybrid model in which startups, corporates and care providers are needed to come up with new solutions to advance care. How can startups, corporates and care providers partner for success?

  • Anselm Tan (Head of Corporate Venturing APAC at Philips)

    Anselm Tan

    Head of Corporate Venturing APAC at Philips
  • Kenath Priyanka Prasad (Founder, Prime Respi | Entrepreneur-in-Residence, Singapore Biodesign)

    Kenath Priyanka Prasad

    Founder, Prime Respi | Entrepreneur-in-Residence, Singapore Biodesign
  • Hui Hong Seow (Programme Director of BlueChilli HealthTech)

    Hui Hong Seow

    Programme Director of BlueChilli HealthTech
  • Chris Hardesty (Director, Life Sciences Practice of KPMG)

    Chris Hardesty

    Director, Life Sciences Practice of KPMG
Q&A and Closing Remarks
Networking Drinks